Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
52.88
-1.05 (-1.95%)
Mar 13, 2025, 1:45 PM EDT - Market open
Disc Medicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 33.05 | 21.86 | 14.04 | 5.76 | 2.96 |
| Research & Development | 96.67 | 69.26 | 33.44 | 25.17 | 18.02 |
| Operating Expenses | 129.72 | 91.13 | 47.48 | 30.93 | 20.98 |
| Operating Income | -129.72 | -91.13 | -47.48 | -30.93 | -20.98 |
| Interest Expense | -0.57 | - | - | - | - |
| Interest & Investment Income | 21.29 | 14.8 | 0.71 | 0.01 | 0.04 |
| Other Non Operating Income (Expenses) | -0 | -0 | -0.06 | -5.05 | - |
| Pretax Income | -109 | -76.33 | -46.83 | -35.97 | -20.94 |
| Income Tax Expense | 0.36 | 0.1 | - | - | - |
| Net Income | -109.36 | -76.43 | -46.83 | -35.97 | -20.94 |
| Net Income to Common | -109.36 | -76.43 | -46.83 | -35.97 | -20.94 |
| Shares Outstanding (Basic) | 28 | 22 | 1 | 1 | 7 |
| Shares Outstanding (Diluted) | 28 | 22 | 1 | 1 | 7 |
| Shares Change (YoY) | 23.71% | 2046.81% | 18.34% | -87.33% | - |
| EPS (Basic) | -3.96 | -3.42 | -45.05 | -40.95 | -3.02 |
| EPS (Diluted) | -3.96 | -3.42 | -45.05 | -40.95 | -3.02 |
| Free Cash Flow | -94.43 | -73.55 | -42.4 | -27.6 | -20.04 |
| Free Cash Flow Per Share | -3.42 | -3.30 | -40.79 | -31.42 | -2.89 |
| EBITDA | -129.56 | -91.03 | -47.39 | -30.9 | -20.96 |
| D&A For EBITDA | 0.16 | 0.1 | 0.09 | 0.03 | 0.02 |
| EBIT | -129.72 | -91.13 | -47.48 | -30.93 | -20.98 |
Source: S&P Capital IQ. Standard template.
Financial Sources.